Synonyms: Amikin® | AMK | Arikayce liposomal® | BB-K8
amikacin is an approved drug (FDA (1981), EMA (2020))
Compound class:
Synthetic organic
Comment: Amikacin is a semi-synthetic aminoglycoside antibacterial that is active against a broad spectrum of Gram-negative organisms, including pseudomonas and some Gram-positive organisms (principally Staphylococcus aureus, including some methicillin-resistant strains). It is a kanamycin derivative. Functionally it binds to the bacterial 30S ribosomal subunit and disrupts protein synthesis, thereby creating its bactericidal effect.
|
|
Bioactivity Comments |
The MIC90 for amikacin's antibacterial activity against non-gentamicin-resistant Escherichia coli clinical isolate is 2 μg/ml in vitro [1]. |